JP2013177406A5 - - Google Patents

Download PDF

Info

Publication number
JP2013177406A5
JP2013177406A5 JP2013092845A JP2013092845A JP2013177406A5 JP 2013177406 A5 JP2013177406 A5 JP 2013177406A5 JP 2013092845 A JP2013092845 A JP 2013092845A JP 2013092845 A JP2013092845 A JP 2013092845A JP 2013177406 A5 JP2013177406 A5 JP 2013177406A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
microparticles
plga
aggregating agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013092845A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013177406A (ja
JP6239851B2 (ja
Filing date
Publication date
Priority claimed from GB0526247A external-priority patent/GB0526247D0/en
Application filed filed Critical
Publication of JP2013177406A publication Critical patent/JP2013177406A/ja
Publication of JP2013177406A5 publication Critical patent/JP2013177406A5/ja
Application granted granted Critical
Publication of JP6239851B2 publication Critical patent/JP6239851B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013092845A 2005-12-22 2013-04-25 オクトレオチドおよび2種またはそれ以上のポリラクチドコグリコリドポリマーを含む徐放性製剤 Active JP6239851B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB0526247A GB0526247D0 (en) 2005-12-22 2005-12-22 Organic compounds
GB0526247.2 2005-12-22
EP06119086 2006-08-17
EP06119086.4 2006-08-17

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2008546248A Division JP2009520727A (ja) 2005-12-22 2006-12-20 オクトレオチドおよび2種またはそれ以上のポリラクチドコグリコリドポリマーを含む徐放性製剤

Related Child Applications (2)

Application Number Title Priority Date Filing Date
JP2014207464A Division JP6178772B2 (ja) 2005-12-22 2014-10-08 オクトレオチドおよび2種またはそれ以上のポリラクチドコグリコリドポリマーを含む徐放性製剤
JP2016115579A Division JP2016216467A (ja) 2005-12-22 2016-06-09 オクトレオチドおよび2種またはそれ以上のポリラクチドコグリコリドポリマーを含む徐放性製剤

Publications (3)

Publication Number Publication Date
JP2013177406A JP2013177406A (ja) 2013-09-09
JP2013177406A5 true JP2013177406A5 (cg-RX-API-DMAC7.html) 2016-08-04
JP6239851B2 JP6239851B2 (ja) 2017-11-29

Family

ID=37772904

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2008546248A Pending JP2009520727A (ja) 2005-12-22 2006-12-20 オクトレオチドおよび2種またはそれ以上のポリラクチドコグリコリドポリマーを含む徐放性製剤
JP2013092845A Active JP6239851B2 (ja) 2005-12-22 2013-04-25 オクトレオチドおよび2種またはそれ以上のポリラクチドコグリコリドポリマーを含む徐放性製剤
JP2014207464A Active JP6178772B2 (ja) 2005-12-22 2014-10-08 オクトレオチドおよび2種またはそれ以上のポリラクチドコグリコリドポリマーを含む徐放性製剤
JP2016115579A Withdrawn JP2016216467A (ja) 2005-12-22 2016-06-09 オクトレオチドおよび2種またはそれ以上のポリラクチドコグリコリドポリマーを含む徐放性製剤

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2008546248A Pending JP2009520727A (ja) 2005-12-22 2006-12-20 オクトレオチドおよび2種またはそれ以上のポリラクチドコグリコリドポリマーを含む徐放性製剤

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2014207464A Active JP6178772B2 (ja) 2005-12-22 2014-10-08 オクトレオチドおよび2種またはそれ以上のポリラクチドコグリコリドポリマーを含む徐放性製剤
JP2016115579A Withdrawn JP2016216467A (ja) 2005-12-22 2016-06-09 オクトレオチドおよび2種またはそれ以上のポリラクチドコグリコリドポリマーを含む徐放性製剤

Country Status (22)

Country Link
US (7) US20090004283A1 (cg-RX-API-DMAC7.html)
EP (3) EP3603623A1 (cg-RX-API-DMAC7.html)
JP (4) JP2009520727A (cg-RX-API-DMAC7.html)
KR (5) KR20130024988A (cg-RX-API-DMAC7.html)
CN (1) CN103251929A (cg-RX-API-DMAC7.html)
AR (1) AR058591A1 (cg-RX-API-DMAC7.html)
AU (1) AU2006328950B2 (cg-RX-API-DMAC7.html)
BR (2) BR122019027412B8 (cg-RX-API-DMAC7.html)
CA (1) CA2631811C (cg-RX-API-DMAC7.html)
CL (1) CL2018003398A1 (cg-RX-API-DMAC7.html)
EC (1) ECSP088560A (cg-RX-API-DMAC7.html)
ES (2) ES2492641T3 (cg-RX-API-DMAC7.html)
IL (1) IL191842A0 (cg-RX-API-DMAC7.html)
IN (1) IN2015DN03936A (cg-RX-API-DMAC7.html)
MA (1) MA30064B1 (cg-RX-API-DMAC7.html)
NO (1) NO20082988L (cg-RX-API-DMAC7.html)
PE (1) PE20071139A1 (cg-RX-API-DMAC7.html)
PL (2) PL1968549T3 (cg-RX-API-DMAC7.html)
PT (2) PT1968549E (cg-RX-API-DMAC7.html)
RU (1) RU2464972C2 (cg-RX-API-DMAC7.html)
TW (2) TWI468172B (cg-RX-API-DMAC7.html)
WO (1) WO2007071395A1 (cg-RX-API-DMAC7.html)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2611020T3 (es) † 2007-06-06 2017-05-04 Debiopharm Research & Manufacturing Sa Composición farmacéutica de liberación lenta hecha de micropartículas
US8470360B2 (en) * 2008-04-18 2013-06-25 Warsaw Orthopedic, Inc. Drug depots having different release profiles for reducing, preventing or treating pain and inflammation
ES2324009B1 (es) * 2007-11-23 2010-05-21 Gp Pharm S.A. Composicion farmaceutica de liberacion sostenida de somatostatina o un analogo suyo.
CA2713339C (en) 2008-01-30 2017-01-17 Novartis Ag Sustained release formulation comprising octreotide and three linear polylactide-co-glycolide polymers
AU2013201877B2 (en) * 2008-01-30 2015-01-29 Novartis Ag Sustained release formulation comprising octreotide and three linear polylactide-co-glycolide polymers
AU2015201581B2 (en) * 2008-09-17 2017-03-09 Amryt Endo, Inc. Pharmaceutical Compositions and Related Methods of Delivery
RU2678833C2 (ru) * 2008-09-17 2019-02-04 Киазма Инк. Фармацевтические композиции и соответствующие способы доставки
AR074603A1 (es) * 2008-12-15 2011-01-26 Novartis Ag Formulacion de deposito de octreotida con niveles de exposicion constantemente altos.uso. metodo. kit
US20100189763A1 (en) * 2009-01-23 2010-07-29 Heather Nettles Controlled release systems from polymer blends
EP2595604B1 (en) * 2010-07-21 2016-03-30 Allergan, Inc. Method of controlling initial drug release of sirna from sustained-release implants
GB201016433D0 (en) 2010-09-30 2010-11-17 Q Chip Ltd Apparatus and method for making solid beads
GB201016436D0 (en) 2010-09-30 2010-11-17 Q Chip Ltd Method of making solid beads
US20120156304A1 (en) * 2010-12-15 2012-06-21 Thomas Tice Branched polyol polyesters, blends, and pharmaceutical formulations comprising same
HUE066287T2 (hu) 2011-04-25 2024-07-28 Geneora Pharma Shijiazhuang Co Ltd Nyújtott leadású mikroszféra risperidon készítmény
CN102488619B (zh) * 2011-12-05 2014-08-06 上海交通大学 连续生产艾塞那肽微球的装置及控制微球释放速度的方法
WO2016084849A1 (ja) * 2014-11-25 2016-06-02 Cbc株式会社 ヤヌス微粒子及びその製造方法
SI3253401T1 (sl) 2015-02-03 2025-07-31 Amryt Endo, Inc. Zdravljenje akromegalije z oralnim oktreotidom
WO2016208685A1 (ja) * 2015-06-26 2016-12-29 オリンパス株式会社 内視鏡電源供給システム
US12396951B2 (en) * 2016-12-27 2025-08-26 Upexmed Co. Ltd. Prevention of local tumor recurrence following surgery using sustainedand/or delayed release of medicaments contained in micro-particles
KR102142026B1 (ko) * 2017-05-31 2020-08-06 주식회사 대웅제약 방출제어가 용이한 서방성 약물 미립자의 제조방법
MX2022002980A (es) 2019-09-16 2022-04-06 Amgen Inc Metodo para la esterilizacion externa de un dispositivo de suministro de farmacos.
CN111214643A (zh) * 2020-03-11 2020-06-02 苏州善湾生物医药科技有限公司 一种基于皮下凝胶缓释的奥曲肽组合物、制备方法及应用
US20210346296A1 (en) * 2020-05-08 2021-11-11 M. Technique Co., Ltd. A biologically active substance uniformly dispersed microsphere and a sustained release formulation comprising the same
JP6852943B1 (ja) * 2020-05-08 2021-03-31 エム・テクニック株式会社 主剤が均一に分散されたマイクロスフェアー及びそれを含有する徐放性製剤
CN119112804A (zh) * 2020-05-08 2024-12-13 M技术株式会社 均匀分散有生理活性物质的微球及含有其的缓释制剂
US11141457B1 (en) 2020-12-28 2021-10-12 Amryt Endo, Inc. Oral octreotide therapy and contraceptive methods
KR102464821B1 (ko) * 2022-04-13 2022-11-09 (주)인벤티지랩 목시덱틴을 포함하는 마이크로 입자 및 이를 포함하는 서방형 주사제 조성물

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3773919A (en) * 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
CY1327A (en) 1979-11-27 1986-06-27 Sandoz Ag Novel polypeptides,processes for their production,pharmaceutical compositions comprising said polypeptides and their use
US4675189A (en) * 1980-11-18 1987-06-23 Syntex (U.S.A.) Inc. Microencapsulation of water soluble active polypeptides
US4897268A (en) * 1987-08-03 1990-01-30 Southern Research Institute Drug delivery system and method of making the same
US5538739A (en) * 1989-07-07 1996-07-23 Sandoz Ltd. Sustained release formulations of water soluble peptides
PH30995A (en) * 1989-07-07 1997-12-23 Novartis Inc Sustained release formulations of water soluble peptides.
HU221294B1 (en) * 1989-07-07 2002-09-28 Novartis Ag Process for producing retarde compositions containing the active ingredient in a polymeric carrier
MY107937A (en) * 1990-02-13 1996-06-29 Takeda Chemical Industries Ltd Prolonged release microcapsules.
CH683149A5 (fr) 1991-07-22 1994-01-31 Debio Rech Pharma Sa Procédé pour la préparation de microsphères en matériau polymère biodégradable.
US5470582A (en) * 1992-02-07 1995-11-28 Syntex (U.S.A.) Inc. Controlled delivery of pharmaceuticals from preformed porous polymeric microparticles
KR100260632B1 (ko) * 1992-12-28 2000-07-01 성재갑 이식형 소마토트로핀 조성물
US5603960A (en) * 1993-05-25 1997-02-18 O'hagan; Derek T. Preparation of microparticles and method of immunization
US5417982A (en) * 1994-02-17 1995-05-23 Modi; Pankaj Controlled release of drugs or hormones in biodegradable polymer microspheres
US6447796B1 (en) * 1994-05-16 2002-09-10 The United States Of America As Represented By The Secretary Of The Army Sustained release hydrophobic bioactive PLGA microspheres
EP0946169B1 (en) * 1996-12-20 2003-02-26 Takeda Chemical Industries, Ltd. Method of producing a sustained-release preparation
AR012448A1 (es) * 1997-04-18 2000-10-18 Ipsen Pharma Biotech Composicion en forma de microcapsulas o de implantes que comprende un excipiente biodegradable, polimero o co-polimero, o una mezcla de talesexcipientes, y una sustancia activa o una mezcla de sustancias activas, procedimiento para la preparacion de una sustancia soluble en agua de elevada
IL133105A (en) * 1997-06-04 2004-09-27 Debio Rech Pharma Sa Implants for controlled release of pharmaceutically active principles and method for making same
ES2169980B1 (es) * 1999-12-17 2003-11-01 Lipotec Sa Microcapsulas para la liberacion prolongada de farmacos.
KR100392501B1 (ko) * 2000-06-28 2003-07-22 동국제약 주식회사 다중 에멀젼법에 의한 서방출성 미립구의 제조방법
EP1344520B1 (en) * 2002-03-15 2007-10-03 Alrise Biosystems GmbH Microparticles and method for their production
US7368126B2 (en) * 2002-11-06 2008-05-06 Guohua Chen Controlled release depot formulations
US20040097419A1 (en) * 2002-11-19 2004-05-20 Holger Petersen Organic compounds
KR100466637B1 (ko) * 2003-06-26 2005-01-13 주식회사 펩트론 서방성 미립구의 혼합 제형을 연속한 단일 공정으로제조하는 방법
EP1660039B1 (en) * 2003-07-18 2016-09-28 Oakwood Laboratories L.L.C. Prevention of molecular weight reduction of the polymer, impurity formation and gelling in polymer compositions
AU2004259209A1 (en) * 2003-07-23 2005-02-03 Pr Pharmaceuticals, Inc. Controlled release compositions
MY158342A (en) * 2003-11-14 2016-09-30 Novartis Ag Pharmaceutical composition
ES2323141T3 (es) * 2004-08-12 2009-07-07 Quest Pharmaceutical Services Composiciones farmaceuticas para el suministro por liberacion controlada de compuestos biologicamente activos.

Similar Documents

Publication Publication Date Title
JP2015044823A5 (cg-RX-API-DMAC7.html)
JP5728128B2 (ja) リスペリドン徐放性ミクロスフェア組成物
RU2008129626A (ru) Композиции с замедленным высвобождением, включающие октреотид и два или более сополимера полилактида и глюколида
JP5882993B2 (ja) 抗精神病薬デポ型注射用組成物
ES2798103T3 (es) Composición farmacéutica inyectable estable de antagonista del receptor de neuroquinina-1 y procedimiento para su preparación
JP2013527213A (ja) 注射用デポ型組成物調合法
Schnieders et al. The effect of porosity on drug release kinetics from vancomycin microsphere/calcium phosphate cement composites
JP2011225600A5 (cg-RX-API-DMAC7.html)
CN112972388B (zh) 卡利拉嗪释放制剂
WO2018166502A1 (zh) 一种水难溶/微溶性药物缓释组合物
KR101930588B1 (ko) 마이크로입자 중에 소마토스타틴 유도체를 포함하는 연장-방출 조성물
CN109414401B (zh) 用于胃肠外给药的生物可降解聚合物微球组合物
Prakapenka et al. Engineering poly (lactic-co-glycolic acid)(PLGA) micro-and nano-carriers for controlled delivery of 17β-estradiol
RU2010135629A (ru) Репаративная форма с замедленным высвобождением, содержащая октреотид и три линейных полимера поли(лактид-со-гликолида)
CN103948911B (zh) 一种棘白菌素类抗真菌药物缓释微球制剂及其制备方法
CN1923189A (zh) 一种紫杉碱类抗癌药物的缓释注射剂
RU2009101810A (ru) Составы ингибиторов ароматазы с замедленным высвобождением
WO2024168022A2 (en) Degarelix polymeric formulations
CN101219113A (zh) 含苯达莫司汀的复方抗癌缓释注射剂
CN104013582B (zh) 一种阿司匹林peg-plga微球的制备方法
KR101764004B1 (ko) 골관절염 예방 또는 치료용, 또는 관절 통증 완화용 주사제 조성물
TH77451B (th) สารผสมตามสูตรที่ออกฤทธิ์ช้าซึ่งประกอบด้วยออกทรีโอไทด์และพอลิแลคไทด์-โค-ไกลโคไลด์ พอลิเมอร์สองตัวหรือมากกว่า
TH93875A (th) สารผสมตามสูตรที่ออกฤทธิ์ช้าซึ่งประกอบด้วยออกทรีโอไทด์และพอลิแลคไทด์-โค-ไกลโคไลด์ พอลิเมอร์สองตัวหรือมากกว่า
CN101219112A (zh) 一种含苯达莫司汀的复方抗癌缓释注射剂
Yan et al. Pharmacokinetics and biodistribution of paclitaxel-loaded microspheres